Turvey S E, Leo S H Boosa, et al. Successful Approach to Treatment of Helicobacter bilis infection in X-Linked agammaglobulinemia. J Clin Immunol. 2012;32(6):1404–8.

Article  PubMed  Google Scholar 

cVorechovský I, Vihinen M, de Saint Basile G, Honsová S, Hammarström L, Müller S, Nilsson L, Fischer A, Smith CI. DNA-based mutation analysis of Bruton’s tyrosine kinase gene in patients with X-linked agammaglobulinaemia. Hum Mol Genet. 1995;4(1):51– 8. https://doi.org/10.1093/hmg/4.1.51. PMID: 7711734.

Peng W, Zhao X, LI X et al. Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease by Inducing Host Immune Disorders. BioMed Research International, 2022, 2022: 1–8.

Segura-López FK. Association betweenHelicobacterspp. Infections and hepatobiliary malignancies: a review. World J Gastroenterol, 2015, 21(5).

Romo-Gonzalez C, Bustamante-Ogando J C, Yamazaki-Nakashimada M, A et al. Infections with enterohepatic Non-H. Pylori Helicobacter species in X-Linked agammaglobulinemia: clinical cases and review of the literature. Front Cell Infect Microbiol, 2022, 11.

Degand N, Dautremer J, PILMIS B, et al. Helicobacter bilis-Associated Suppurative Cholangitis in a patient with X-Linked agammaglobulinemia. J Clin Immunol. 2017;37(7):727–31.

Article  CAS  PubMed  Google Scholar